Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Equivalence Study of Epoetin Alfa Deep Tank vs Roller Bottle in CKD Anemia
NCT00146224Phase 3Completed
- Sponsor
- Amgen
- Start
- Sep 2005
- Primary completion
- Jan 2007
- Modality
- Biologic, rProtein (Recombinant Protein)
01
Overview
Phase 3, randomised, double-blind trial of epoetin alfa in anemia (2 arms), sponsored by Amgen. Primary endpoints: Ratio of weekly dose at the evaluation period to the weekly dose at baseline and Change in Hemoglobin level between the screening period and the evaluation period. Started Sep 2005; status: completed.
02
Drugs
epoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00146224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00146224.